|
Patogen and HIPRA have collaborated to produce a comprehensive review of Yersiniosis, a significant disease affecting farmed fish globally. This partnership highlights the importance of addressing Yersiniosis, which impacts species like rainbow trout and Atlantic salmon.
Coinciding with this review, HIPRA launches ICTHIOVAC® ERM, a groundbreaking vaccine offering broader protection against Yersinia ruckeri, earlier and long-lasting protection, also improving biomass vaccination efficiency, reducing the required vaccine volume and storage and transportation costs. This innovative solution promises to enhance the health and sustainability of salmon farming.
|
